Sandu Pharmaceuticals Limited (BOM:524703)
India
· Delayed Price · Currency is INR 51.54
-0.88 (-1.68%)
At close: Jun 9, 2025
Sandu Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Cash & Equivalents | 26.53 | 10.04 | 22.76 | 9.39 | 45.28 | Upgrade
|
| Short-Term Investments | - | 2.02 | 0.2 | 32.33 | 71.28 | Upgrade
|
| Cash & Short-Term Investments | 26.53 | 12.06 | 22.96 | 41.71 | 116.56 | Upgrade
|
| Cash Growth | 119.93% | -47.45% | -44.96% | -64.21% | 656.09% | Upgrade
|
| Accounts Receivable | 47.57 | 48.68 | 47.92 | 39.91 | 53.48 | Upgrade
|
| Other Receivables | - | 0.62 | 3.17 | 4.28 | 1.24 | Upgrade
|
| Receivables | 47.57 | 50.32 | 52.13 | 45.09 | 54.92 | Upgrade
|
| Inventory | 141.49 | 122.51 | 143.26 | 112.72 | 111.38 | Upgrade
|
| Prepaid Expenses | - | 1.15 | 0.76 | 0.87 | 1.81 | Upgrade
|
| Other Current Assets | 47.4 | 37 | 36.35 | 36.08 | 20.76 | Upgrade
|
| Total Current Assets | 262.99 | 223.04 | 255.45 | 236.47 | 305.43 | Upgrade
|
| Property, Plant & Equipment | 181.22 | 178.43 | 169.86 | 164.5 | 161.06 | Upgrade
|
| Long-Term Investments | 112.74 | 122.33 | 115.61 | 91.39 | 2.46 | Upgrade
|
| Other Intangible Assets | 0.24 | 0.35 | 0.51 | 0.35 | 0.68 | Upgrade
|
| Other Long-Term Assets | - | 0 | 0.24 | 0.14 | 0 | Upgrade
|
| Total Assets | 557.19 | 524.15 | 541.66 | 492.85 | 469.63 | Upgrade
|
| Accounts Payable | 44.87 | 41.95 | 83.98 | 68.18 | 66.7 | Upgrade
|
| Accrued Expenses | 53.84 | 32.98 | 29.07 | 25.65 | 40.88 | Upgrade
|
| Short-Term Debt | - | - | - | - | 0.19 | Upgrade
|
| Current Portion of Leases | 0.58 | 0.03 | - | - | - | Upgrade
|
| Current Income Taxes Payable | - | 19.12 | 13.25 | 15.28 | 8.32 | Upgrade
|
| Current Unearned Revenue | - | 5.15 | 7.3 | 6.06 | 5.34 | Upgrade
|
| Other Current Liabilities | 21.57 | 7.19 | 5.24 | 3.57 | 3.76 | Upgrade
|
| Total Current Liabilities | 120.86 | 106.41 | 138.83 | 118.74 | 125.19 | Upgrade
|
| Long-Term Leases | 4.19 | 0.6 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 11.96 | 11.21 | 10.42 | 9.37 | 9.53 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | -0 | Upgrade
|
| Total Liabilities | 137.02 | 118.22 | 149.25 | 128.1 | 134.72 | Upgrade
|
| Common Stock | 96.61 | 96.61 | 96.61 | 88.11 | 79.21 | Upgrade
|
| Additional Paid-In Capital | - | 27.58 | 27.58 | 18.49 | 8.98 | Upgrade
|
| Retained Earnings | - | 180.88 | 171.95 | 161.8 | 144.76 | Upgrade
|
| Comprehensive Income & Other | 323.56 | 100.86 | 96.27 | 96.35 | 101.96 | Upgrade
|
| Shareholders' Equity | 420.17 | 405.93 | 392.41 | 364.75 | 334.91 | Upgrade
|
| Total Liabilities & Equity | 557.19 | 524.15 | 541.66 | 492.85 | 469.63 | Upgrade
|
| Total Debt | 4.78 | 0.63 | - | - | 0.19 | Upgrade
|
| Net Cash (Debt) | 21.76 | 11.43 | 22.96 | 41.71 | 116.37 | Upgrade
|
| Net Cash Growth | 90.33% | -50.21% | -44.96% | -64.16% | 3823.48% | Upgrade
|
| Net Cash Per Share | 2.24 | 1.18 | 2.43 | 4.91 | 16.43 | Upgrade
|
| Filing Date Shares Outstanding | 9.6 | 9.66 | 9.66 | 8.81 | 7.92 | Upgrade
|
| Total Common Shares Outstanding | 9.6 | 9.66 | 9.66 | 8.81 | 7.92 | Upgrade
|
| Working Capital | 142.13 | 116.63 | 116.62 | 117.74 | 180.24 | Upgrade
|
| Book Value Per Share | 43.77 | 42.02 | 40.62 | 41.40 | 42.28 | Upgrade
|
| Tangible Book Value | 419.93 | 405.58 | 391.91 | 364.4 | 334.23 | Upgrade
|
| Tangible Book Value Per Share | 43.74 | 41.98 | 40.57 | 41.36 | 42.20 | Upgrade
|
| Buildings | - | 86.16 | 85.84 | 81.31 | 81.31 | Upgrade
|
| Machinery | - | 97.61 | 81.87 | 75.42 | 71.83 | Upgrade
|
| Construction In Progress | - | - | 4.2 | 4.82 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.